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Introduction gain SNR. Thus, the purpose of the present study was toThe role of diffusion-weighted MRI (DWI) in the char-
acterization and differentiation of breast lesions remains a
subject of intensive research.1e3 In breast DWI, the use of an
effective fat-suppression technique is especially critical. As
the MRI signal has contributions from both water and fat
components,4 it is essential to efficiently eliminate the lipid
signal. The fat fraction in breast tissue can be high, and as
the apparent diffusion coefficient (ADC) of fat is much lower
than that of water within lesions and/or normal glandular
tissue,5 the presence of lipids may compromise an accurate
ADC estimate.
Multiple fat-suppression techniques are currently avail-
able [short tau inversion recovery (STIR), spectral adiabatic
inversion recovery (SPAIR), frequency-selective fat saturation
(FatSat), water-selective excitation or the Dixon technique].
Each one is based on different physical phenomena,4e6 and
previous studies have described their variable efficiency in
lesion detection, and ADC estimates.7e10
Given that the available techniques are not equally
robust to the static magnetic field (B0) and radiofrequency
magnetic field (B1) inhomogeneities, it is important to
compare their performance on breast DWI at 3 T. Previous
studies7,8,11 have used different techniques for fat suppres-
sion: Bogner et al.7 used STIR, whereas Peters et al.8 and El
Khouli et al.11 used SPAIR, which makes direct comparisons
difficult. For example, comparing results previously ob-
tained by the present authors’ group using a SPAIR-based
sequence12 with those reported by Bogner et al.7 using
STIR (b-values 50 and 1000 s/mm2 in both cases), similar
ADC values were obtained for malignant and normal glan-
dular tissue, but not for benign lesions, which could
potentially be related to differences in fat-suppression
efficiency.
Echo planar imaging (EPI) is a fast acquisition technique
commonly used in breast DWI. It enables high imaging
speed at the cost of being prone to chemical shift artefacts
and geometric distortions.13 A common strategy to decrease
these artefacts is to use parallel imaging (PI), an image
reconstruction technique that makes use of sensitivity dif-
ferences between different coil channels to perform spatial
encoding, enabling a reduction in the number of phase-
encoding steps. This in turn leads to a shorter readout
window and hence reduced geometric distortion in the
images.14 Another study developed by the present authors
comparing DWI-STIR and -SPAIR at 3 T including PI15 [in
press] revealed similar contrast-to-noise ratio (CNR) and
signal-to-noise ratio (SNR) except for benign lesions, and
comparable ADC values for benign and malignant lesions.
However, some authors reported a decrease in SNR and
CNR with PI as the echo time (TE) shortening achievable
with PI can be insufficient to compensate for the g-factor
noise penalty, which depends on the coil geometry and
reflects the difference in sensitivity of the available chan-
nels along the phase encode direction.16,17 Given that the
present DWI sequence includes higher b-values (b ¼ 2000
and 3000 s/mm2) the decision was made to exclude PI tocompare quantitatively DWI-STIR and -SPAIR when no PI is
used regarding SNR and CNR, fat-suppression uniformity,
and ADC quantification for lesion differentiation and char-
acterization in the clinical setting.
Materials and methods
Patients and lesions
The present study is included in a wider investigation
focusing on the application of DWI to study breast lesions,
for which approval has been obtained from the institutional
review board (code CES 276/13). This prospective study was
performed on women with clinical indication for breast
MRI. Written informed consent was obtained from all
patients.
Women were excluded from this study if they (1) had
undergone chemotherapy or radiotherapy 24 months prior
to the MRI examination (three women with four lesions);
(2) had had surgery <2 years before; (3) had completed
hormone-replacement therapy within 24 months of the
examination; (4) had breast implants; and (5) only one fat-
saturation technique was performed (two womenwith two
lesions).
Inclusion criteria for lesion analysis were (1) a minimum
size of 0.7 cm in the dynamic contrast-enhanced (DCE)
sequence; (2) a definitive outcome obtained through his-
tology (core needle biopsy or excised surgery), and/or a
minimum 2 year follow-up by mammography, ultrasound,
or MRI.
All premenopausal women performed breast MRI ex-
amination between the 7th and 14th day of their menstrual
cycle to diminish enhancement of normal glandular tissue
after contrast medium injection.18 For women who had
undergone biopsy before MRI examination, a minimum
interval of 10 days prior to the MRI examination was
enforced to minimize signal intensity changes due to po-
tential haemorrhage and/or oedema.
In the benign lesions group, only solid lesions were
included in the ADC calculation. Cystic lesions were
excluded as their high ADC would bias ADC estimates.
Acquisition protocol
All MRI examinations were performed using a 3 T system
(Magnetom Tim Trio, Siemens, Erlangen, Germany)
equipped with a four-channel dedicated breast radio-
frequency (RF) coil (Invivo Corporation). Patients were
examined in a resting prone position with the total volume
of the breast in the coil compartment.
The imaging protocol included axial T2-weighted (W)
turbo spin-echo (TSE); sagittal three-dimensional (3D) T1W
fast low-angle shot (FLASH) without fat suppression;
sagittal T2W TSE STIR; sagittal DWI; axial 3D T1W FLASH
DCE with SPAIR for fat suppression, acquired after
gadobenate dimeglumine injection (MultiHance; Bracco,
Milan, Italy), and a sagittal 3D T1W FLASH post-contrast
sequence with water-selective excitation as the fat-
suppression technique.
Before the DCE pulse sequence, two DW single-shot
spin-echo EPI (DW-SS-SE-EPI) sequences with either STIR
or SPAIR as the fat-suppression module were carried out.
The DW images were acquired in the sagittal plane for each
breast, with the sensitizing diffusion gradients applied
along the x, y and z directions to generate three-scan-trace
images. Volume shimming adjusted to the field-of-view
(FOV) was performed to improve magnetic field homoge-
neity. Table 1 describes the details of DWI-STIR and -SPAIR.
A minimum TE of 106 (and 108 ms) had to be applied to
include b-values 2000 and 3000 s/mm2. These were used to
explore the non-Gaussian distribution of diffusion.19
Considering that at 3 T a transverse relaxation time T2 of
71  6 ms has been reported for normal fibroglandular
tissue,20 extending the TE from 78 to 106 and 108 ms,
respectively for SPAIR and STIR, resulted in a signal loss of
34%. This was compensated for by increasing the number of
excitations (NEX) to 3, resulting in a final SNR improvement
of 17% and 14%, for SPAIR and STIR, respectively.
To simplify the analysis, only the pair of DWI with b-
values of 50 and 1000 s/mm2 and derived ADCwas included
in the present study. This choice was based on a previous
study developed by the authors to determine the best pair
of b-values for breast lesion differentiation.12Image analysis
The image-processing platform of the MRI machine and
the software provided by the manufacturer were used to
analyse the images [Siemens Medical Systems, work in
progress (WIP) version 17A]. The same experienced breast
imaging radiologist, with 7 years of experience, reported all
the examinations. Lesions were evaluated according to their
morphological and kinetic characteristics, as described by
the American College of Radiology (ACR) Breast ImagingTable 1
Main imaging parameters for diffusion-weighted imaging short tau inversion
recovery (DWI-STIR) and spectral adiabatic inversion recovery (SPAIR).
Parameters DWI
Sequence SS-SE-EPI SS-SE-EPI
Fat suppression STIR SPAIR
Orientation Sagittal Sagittal
TR/TE (ms) 4900/108 4900/106
TI (ms) 240 _
FOV (mm2) 250  250 250  250
Matrix (pixels) 84  128 84  128
Phase encoding direction head-to-feet head-to-feet
Slice thickness (mm) 5 5
Voxel (mm3) 2  2  5 2  2  5
NEX 3 3
Bandwidth (Hz/pixel) 1628 1628
Scan time (min) 5:58 5:58
b-values (s/mm2) 50, 200, 400, 600, 800,
1000, 2000 and 3000
50, 200, 400, 600,
800, 1000, 2000
and 3000
DWI, diffusion-weighted imaging; FOV, field of view; NEX, number of exci-
tations; SPAIR, spectral adiabatic inversion recovery; SS-SE-EPI, single-shot
spin-echo echo planar imaging; STIR, short tau inversion recovery; TI,
inversion time; TR/TE, repetition time/echo time.Reporting and Data System-MRI (BIRADS-MRI).21 Lesion
size was measured using the ruler function on DCE images
and considering its maximum diameter.
DWI datasets were retrospectively analysed by two
radiological researchers in consensus (with 6 and 11 years
of experience in breast MRI). At the time of interpretation,
both were blinded to the final histological results. To iden-
tify lesions in the DW images, the conventional MRI report
description and the visual inspection of the T1W, T2W, the
subtracted early DCE, and the post-contrast images were
used as reference for both fat-saturation techniques.
Fixed, circular region of interest (ROI) of 0.25 cm2 were
used to measure the signal intensity in lesions, normal
glandular tissue, and noisy background (along the readout
direction to avoid including EPI ghosts, which are image
artefacts that can appear along the phase-encoding direc-
tion of the image). The same area and section were selected
for both fat-saturation techniques when drawing the ROIs.
These were defined at b ¼ 1000 s/mm2, in the section that
showed the maximum dimension and best definition of the
lesion and its margins within the area of highest hyper-
intensity. Care was taken to avoid areas of necrosis or
hyperintensity due to T2 shine-through effect, through vi-
sual comparison with T1W and T2W images. The ROIs were
then copied to the corresponding section at b ¼ 50 s/mm2.
In women with unilateral lesions, normal glandular tis-
sue signal intensity was measured in the central section of
the contralateral breast at b ¼ 1000 s/mm2, avoiding areas
of fatty tissue, and then copied to b ¼ 50 s/mm2.
For both fat-saturation techniques, the analysis of SNR,
CNR, and suppression uniformity was performed at
b ¼ 1000 s/mm2 for lesions and normal glandular tissue.
SNR was calculated using the equation22
SNR ¼ SIlesion
.
SDbackground;
where SIlesion is the mean signal intensity in the lesion and
SDbackground is the average of the background noise in the
air. To estimate background noise, the section that better
depicted the lesion was chosen, and measurements were
performed placing three ROIs of 0.25 cm2 in the air; 1 cm
above, below and anterior to the nipple. Background noise
was calculated as the average of the standard deviation (SD)
of the three ROIs measurements as reported by Woodhams
et al.23
To estimate the CNR between lesion and normal glan-
dular tissue, signal intensity of normal tissue was measured
in the same side as the lesion, and the CNR estimated with
the following equation.
CNR ¼ ðSIlesion  SInormal tissueÞ
.
SDbackground;
where SIlesion is the signal intensity of the lesion and
SInormal tissue is the signal intensity of the normal fibro-
glandular tissue in the same breast, SDbackground is the
average of the SD in the background signal.
For each DWI technique, fat-saturation uniformity was
assessed considering the average of the SD of the signal
intensity measured in the normal glandular tissue, as
although these measurements are affected by noise (higher
SNR should lead to lower SD), heterogeneous fat saturation
should lead to higher SD within the ROIs.
For both techniques, ADC maps were estimated for each
lesion and for normal glandular tissue with b-values 50 and
1000 s/mm2, using the equation
ADC ¼ ln½Sðb1Þ  ln½Sðb2Þ
b2  b1
where S(b) represents the signal intensity measured for
each b-value.
Statistical analysis
To characterize the study population, a descriptive
analysis was performed. The KolmogoroveSmirnov test was
used to verify the distribution of the data. For each tech-
nique and by tissue type, mean values of SNR, CNR, uni-
formity of fat suppression, and ADCs were calculated. The
differences were evaluated with the ManneWhitney test
and the independent samples Student’s t-test depending on
the probability distribution of the data.
Comparison between DWI-STIR and -SPAIR regarding
image quality parameters and ADC was performed using
the Wilcoxon signed-rank test or the paired samples Stu-
dent’s t-test. Spearman’s and Pearson’s tests were used to
evaluate the correlation in measurements between DWI-
STIR and -SPAIR.
For each fat-suppression technique, the ADC cut-off
point was calculated, considering Youden statistics and
the minimal distance between the receiver operating
characteristics (ROC) curves and the ideal point of co-
ordinates (0, 1) where both the sensitivity and specificity
have a maximum value of 1. The diagnostic performance for
each technique in lesion discrimination was evaluated,
including the use of the McNemar test.
All analyses were performed using the PASW Statistics
V21 software. A p-value of<0.05 was considered to indicate
a significant difference.Results
Patients and lesion characteristics
Ninety-two women (mean  standard deviation age of
48  12 years; range 21e78 years) with 114 lesions were
successfully scanned with DWI-STIR and -SPAIR. Thirty-
seven women were post-menopausal. One hundred and
four lesions were mass (91.2%) and 10 non-mass lesions
(8.8%). Among the 114 lesions, 74 were classified as malig-
nant and 40 as benign. Histological results were obtained
for 99 lesions by biopsy and/or surgery. Mean size for
benign lesions was 13.9 mm, whereas for malignant le-
sions it was 25  15 mm. Significant differences in size by
lesion typewere found (p< 1104). For malignant lesions
histological results were nine ductal carcinoma in situ; three
lobular carcinoma in situ; 35 invasive ductal carcinoma; 18
invasive lobular carcinoma; one mucinous carcinoma; eightclassified as others malignant lesions not otherwise speci-
fied (NOS).
For 25 benign lesions, histological analysis revealed 12
fibroadenomas; six epithelial proliferative lesions; two
papillomas; one hamartoma; four other benign, namely one
sclerosing adenosis, one fibrocystic change, two epithelial
proliferative lesions with miofibroblastic proliferation and
infiltrative inflammation.
For eight benign lesions (five were fibroadenomas, two
were fibrocystic change, and one was a sclerosing adenosis)
histological results were available prior to the study. These
lesions were diagnosed in womenwith BRCA mutation that
perform annual MRI follow-up. The remaining seven benign
lesions were cysts identified by ultrasound and DWI-MRI,
but which were excluded from the ADC analysis.
Fig 1 illustrates an invasive ductal carcinoma in the left
breast of a 38-year-old woman. MRI included STIR (a) dy-
namic (b) and DW images using -STIR (c,d) and -SPAIR (e,f)
(b1000 s/mm2 and ADC maps, respectively).
Comparison between DWI-STIR and -SPAIR
Differences in mean ADC values, SNR, CNR, and satura-
tion uniformity for each fat-suppression technique and
comparison between DWI-STIR and -SPAIR, as well as cor-
relation between measurements are presented in Table 2.
Mean ADC values were higher for DWI-STIR. For both
DWI-STIR and -SPAIRmean ADC values of malignant lesions
were lower (1.18  0.42; 1.11  0.04  103 mm2/s) than
benign lesions (1.92  0.45; 1.80  0.38  103 mm2/s),
with significant differences between them (p < 1  104;
p < 1  104), respectively.
DWI-STIR showed no differences between benign and
malignant lesions for SNR, CNR or fat-suppression unifor-
mity (p ¼ 0.588; p ¼ 0.287; p ¼ 0.701, respectively). For
DWI-SPAIR there were also no differences in SNR, CNR, and
fat-suppression uniformity between benign and malignant
lesions (p ¼ 0.636; p ¼ 0.252; p ¼ 0.549). Fat-suppression
uniformity was better for DWI-STIR than for -SPAIR
(0.73  0.47 versus 1.42  0.93).
Comparison between fat-suppression techniques
showed significant differences in ADC values for benign
(p ¼ 0.013) and malignant lesions (p ¼ 0.001), with high
correlation between measurements for lesion type (benign:
r ¼ 0.785; p < 1  104 and malignant: r ¼ 0.769;
p < 1 104). ADC values for normal glandular tissue were
similar (p ¼ 0.072), with a strong correlation between
measurements (r ¼ 0.813; p < 1  104).
Higher SNR was found for DWI-SPAIR than -STIR, with
significant differences for benign (p ¼ 0.017), malignant
(p ¼ 0.001) and normal glandular tissue (p ¼ 0.035), with
high correlation for benign (r ¼ 0.754; p < 1  104) and
malignant lesions (r ¼ 0.606; p < 1  104). For normal
glandular tissue, no correlation was found between DWI-
STIR and -SPAIR (r ¼ 0.047; p ¼ 0.781).
CNR was also higher for DWI-SPAIR than -STIR, regard-
less of lesion type, with significant differences in CNR values
for malignant (p ¼ 0.005) and no differences for benign
lesions (p ¼ 0.063). Also, no correlations were observed for
Figure 1 Thirty-eight year-old woman with grade III invasive ductal carcinoma, with in situ component. Axial bilateral STIR (a) and dynamic
sequence with clear definition of irregular lesion border (b), and DWI acquisitions [DWI-STIR b ¼ 1000 s/mm2/ADC map (c,d); DWI-SPAIR
b ¼ 1000 s/mm2/ADC map (e,f)]. The lesion is highly cellular, with increased signal intensity on STIR and on both DWI sequences (*), with
the respective low signal intensity on the ADC maps (**).CNR between techniques for malignant (r ¼ 0.399;
p ¼ 0.073) or benign (r ¼ 0.679; p ¼ 0.094) lesions.
Comparison between DWI-STIR and -SPAIR in fat-
suppression uniformity presented significant differences
for benign (p < 1  104), malignant (p < 1  104) and all
(benign plus malignant) lesions (p < 1  104). Also, no
correlations were observed between techniques for benign
(r ¼ 0.224; p ¼ 0.282) and malignant (r ¼ 0.282; p ¼ 0.061)
lesions, although a weak and significant correlation was
observed when considering all lesions together (r ¼ 0.278;
p ¼ 0.020).
Diagnostic performance of DWI-STIR and -SPAIR
To assess the influence of the fat-saturation technique in
lesion discrimination, ROC analysis was performed to
calculate the optimal ADC thresholds for DWI-STIR and
-SPAIR (Fig 2). The area under the curve (AUC) was higher
for DWI-SPAIR (89.2%; 95% CI: 83.5e94.9) than -STIR (87.7%;
95% CI: 81.5e93.9). The ADC threshold for discriminating
benign from malignant lesions was 1.42  103 mm2/s and1.46  103 mm2/s for DWI-STIR and -SPAIR, respectively.
Lesions with mean ADC values below the respective
threshold for each fat-saturation technique were classified
as malignant. Based on those ADCs thresholds, diagnostic
performance is presented in Table 3.
DWI-SPAIR showed absolute higher sensitivity in lesion
discrimination than -STIR. For DWI-SPAIR, false-positive
cases were four fibroadenomas, one sclerosing adenosis,
one papilloma, two epithelial proliferative changes, one of
which presented miofibroblastic proliferation and infiltra-
tive inflammation. False-negative cases were two ductal
carcinoma in situ, five extensively spread invasive lobular
carcinomas, three invasive ductal carcinomas, and one
lesion classified as NOS with signet ring cell and mucin.
DWI-STIR displayed two less false-positive cases: three
fibroadenomas, one papilloma, two epithelial proliferative
lesions, one of which presented miofibroblastic prolifera-
tion and infiltrative inflammation. These are the same le-
sions misclassified by DWI-SPAIR. On the other hand, DWI-
STIR revealed four more false-negative cases than DWI-
SPAIR, namely two invasive lobular carcinomas, one
Table 2
Mean  standard deviation apparent diffusion coefficient (ADC) values and image quality parameters for each fat-saturation technique and comparison be-
tween DWI-STIR and -SPAIR.
DWI-STIR
(Mean  SD)
Benign versus
Malignant STIR
p-valuea
DWI-SPAIR
(Mean  SD)
Benign versus
Malignant SPAIR
p-valueb
STIR versus SPAIR
p-valuec
STIR-SPAIR correlation
(rS)d
ADC (103 mm2/s)
Benign 1.92  0.45 <1  104 1.80  0.38 <1  104 0.013 0.785 (p < 1  104)
Malignant 1.18  0.42 1.11  0.04 0.001 0.769 (p < 1  104)
Normal tissue 1.86  0.41 e 1.79  0.38 e 0.072 0.813 (p < 1  104)
SNR
Benign 59.8  37.4 0.588 76.6  57.7 0.636 0.017 0.754 (p < 1  104)
Malignant 62.3  32.8 81.8  48.7 0.001 0.606 (p < 1  104)
Normal tissue 26.1  19.8 e 33.4  19.4 e 0.035 0.047 (p ¼ 0.781)
CNR
Benign 53.2  43.6 0.287 70.3  50.0 0.252 0.063 0.679 (p ¼ 0.094)
Malignant 31.9  20.0 57.6  42.0 0.005 0.399 (p ¼ 0.073)
Uniformity
Benign 0.70  0.38 0.701 1.50  0.98 0.549 <1  104 0.224 (p ¼ 0.282)
Malignant 0.74  0.52 1.37  0.91 <1  104 0.282 (p ¼ 0.061)
All lesions 0.73  0.47 e 1.42  0.93 e <1  104 0.278 (p ¼ 0.020)
ADC, apparent diffusion coefficient; CNR, contrast-to-noise ratio; DWI, diffusion-weighted imaging; SD, standard deviation, SNR, signal-to-noise ratio; SPAIR,
spectral adiabatic inversion recovery; STIR, short tau inversion recovery.
a Differences in ADC values and image-quality parameters between tissue types for DWI-STIR.
b Differences in ADC values and image-quality parameters between tissue types for DWI-SPAIR.
c Comparison between DWI-STIR and -SPAIR regarding ADC values and image-quality parameters.
d Spearman’s rank correlation between DWI-STIR and -SPAIR for ADC values and image-quality parameters.invasive ductal carcinoma with in situ component, and one
mucinous carcinoma.
The positive and negative predictive values for DWI-STIR
and -SPAIR were 90.8% and 88.7% and 69.4% and 74.4%,
respectively.
Accuracy in lesion discrimination was 81.6% for DWI-
STIR and 83.3% for DWI-SPAIR. Regarding the comparison
in diagnostic performance, no differences were observed
between DWI-STIR and -SPAIR (p ¼ 0.096). The comparison
between diagnostic performance and histological results
also showed no differences for DWI-SPAIR (p ¼ 0.481) butFigure 2 ROC curves used to differentiate benign and malignant le-
sions based on mean ADC values for each fat suppression technique,
namely DWI-STIR and -SPAIR.significant differences were observed for DWI-STIR
(p ¼ 0.023).
Discussion
Achieving adequate elimination of the lipid signal is
challenging, especially at magnetic field strengths 3 T due
to increased susceptibility artefacts, image ghosting, and
larger chemical shifts that can be present when compared
to 1.5 T.14 To address these issues while preserving image
quality, the use of an adequate fat-suppression method isTable 3
Diagnostic performance of DWI-STIR and -SPAIR in lesion discrimination.
DWI-STIR DWI-SPAIR
ADC cut-off (103 mm2/s) 1.42 1.46
False positive 6 8
False negative 15 11
True positive 59 63
True negative 34 32
Sensitivity, 95% CI (%) 79.7 [70.6; 88.9] 85.1 [77.0; 93.2]
Specificity, 95% CI (%) 85 [73.9; 96.1] 80 [67.6; 92.4]
Positive predictive value,
95% CI (%)
90.8 [83.7; 97.8] 88.7[81.4; 96.1]
Negative predictive value,
95% CI (%)
69.4 [56.5; 82.3] 74.4 [61.4; 87.5]
Accuracy, 95% CI (%) 81.6 [74.5; 88.7] 83.3 [76.5; 90.2]
AUC, 95% CI (%) 87.7 [81.5; 93.9] 89.2 [83.5; 94.9]
Diagnostic performance
McNemar test (p-value)a
0.023 0.481
ADC, apparent diffusion coefficient; AUC, area under the curve; CI, confi-
dence interval.
a The McNemar test was used to compare the diagnostic performance of
DWI-STIR and SPAIR methods regarding histological results. Also, the com-
parison of the diagnostic performances of DWI-STIR and SPAIR methods
between themselves held a p ¼ 0.096.
essential to mitigate image artefacts and promote adequate
SNR and CNR.24 Also, unsuppressed fat signal interferes
with the diffusivity characteristics of the underlying tissue,
resulting in underestimation of ADC values.25,26
Different fat-suppression techniques are available for
breast DWI.27 In the present study DWI-STIR and -SPAIR
were investigated for breast DWI at 3 T. These fat-saturation
techniques were chosen because of their physical charac-
teristics and robustness to deal with B0 and B1 in-
homogeneities that are more pronounced at higher fields.14
Previous investigations focusing on this subject were
performed mainly at 1.5 T, and some controversy still exists
regarding the impact of the fat-suppression module on
image quality and ADC quantification.5,9,28,29 Differences in
DWI pulse sequence parameters or the use of different fat-
suppression methods prevent a direct comparison between
studies. Using PI, lower SNR and CNR had been reported by
Jin et al.16 To isolate the effect of the fat-suppression tech-
nique, all other acquisition parameters were kept as con-
stant as possible.
DWI-SPAIR showed higher SNR and CNR than -STIR. SNR
results are in agreement with a previous study developed
by Baron et al.,27 who found a slightly higher SNR for DWI-
SPAIR than -STIR in normal glandular tissue, without sig-
nificant differences. The most likely explanation for these
findings is that STIR is based on a non-selective 180 radi-
ofrequency inversion pre-pulse that inverts not only lipids
but also water spins; this leads to reduced water signal due
to incomplete magnetization recovery, resulting in lower
SNR. Nonetheless, STIR has the advantage of being largely
immune to B0 inhomogeneities.30 Conversely, DWI-SPAIR
only inverts spins centred at the precessional frequency of
lipids, allowing the overall water signal to be unchanged
and higher SNR to be obtained.31 As an advantage, SPAIR is
relatively indifferent to B1 inhomogeneities due to the use
of adiabatic inversion pulses (RF pulses with variable fre-
quency).28,32 Significant differences were found in the CNR
values of malignant lesions between DWI-SPAIR and -STIR,
indicating that lesion visualization may be hampered in
DWI-STIR, although in the present series all lesions were
detected using either saturation technique.
Fat-suppression uniformity was better for DWI-STIR
when compared to -SPAIR for all the tissues analysed. One
explanation for the incomplete suppression of the lipid
signal lies in the fact that SPAIR is based on spectrally se-
lective pulses that only suppress the contribution from the
largest lipid peak at a resonance frequency of approximately
3.5 ppm relative to water.4 Minor lipid peaks at different
resonance frequencies33 remain unsuppressed and still
contribute to the final signal intensity.34,35 Additionally,
STIR seems to produce a more spatially homogeneous
suppression throughout the image. Given that the acquisi-
tion parameters are very similar for both DW sequences, the
differences found on the image-quality parameters can be
attributed to the fat-suppression module applied.
Differentiation and characterization of benign and ma-
lignant lesions is based on their ADC. When comparing the
present mean ADC values for benign and malignant lesions
and normal glandular tissue with previous studies that alsodid not apply PI, results are within the same range.7,9 The
lower ADC values found with DWI-SPAIR when compared
to -STIR, for both benign and malignant lesions are
compatible with incomplete lipid suppression with -SPAIR.
As the lipid signals are spatially mapped onto an incorrect
location, regions of lesion/parenchyma may be contami-
nated, and the ADC estimates affected. As lipids have been
reported to have low ADC values5 if their signal is not
completely eliminated, a lower ADC will be measured as
found here with DWI-SPAIR. The results of the present
study indicate significant differences in the ADCs and
image-quality parameters, except for ADCs in normal
glandular tissue and CNR in benign lesions. Furthermore, a
high correlation in measurements between fat-suppression
techniques was found and the ADCs were monotonically
related, which means that the contribution of the lipid
signals, although varying according to the fat suppression
used, affects each individual lesion in a similar way.
Theoretically, the ADC value in a lesion without adipose
tissue should be exactly the same for both fat-saturation
techniques. However, lesions present heterogeneous envi-
ronments including variable fat content, and therefore,
differences in ADC estimates were expected. The results of
the present study confirm the presence of fat content in
lesions, as translated by the difference in mean ADC values
using STIR and SPAIR. Also, the percentual difference of
these ADC values for benign (6.7%) and malignant lesions
(6.3%) are observed to be larger than for normal tissue
(3.9%), which suggests that lesions have variable fat content.
These results also agree with a previous study that reported
higher fat content in benign compared to malignant
lesions.36
The diagnostic performance of breast DWI relies on the
individual ADC value and established thresholds for lesion
discrimination.37 In a recent meta-analysis ADC cut-off
values to differentiate benign from malignant lesions have
been reported ranging from 1.1  103 to 1.6  103 mm2/
s.38 The thresholds used in the present study are in the
range of those previously reported for b-values 0 and
1000 s/mm2 (1.46  103 mm2/s for DWI-SPAIR and
1.42  103 mm2/s for DWI-STIR). Assuming the individual
ADC threshold, DWI-SPAIR showed higher sensitivity, ac-
curacy, and an AUC slightly higher than -STIR. However,
specificity was higher for DWI-STIR than -SPAIR (85% versus
80%). The comparison between fat-suppression methods
revealed similar diagnostic performance (p ¼ 0.096).
Nevertheless, when each fat suppression was compared
with the reference standard adopted in breast lesion clas-
sification, DWI-SPAIR seems be preferable to -STIR.
False-positive and -negative cases were found for both
fat-saturation methods. Six of the false-positive cases were
misclassified by both techniques, namely three fibroade-
noma, one papilloma, and two epithelial proliferative le-
sions. Additionally, DWI-SPAIR failed to classify two
additional lesions (one fibroadenoma and one sclerosing
adenosis). Different causes could explain these results, such
as the presence of fibrosis and increased cellularity and/or
increased cell proliferation, which restricts water diffusivity
and lowers the ADC values.
1. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and ma-
lignant breast lesions using diffusion-weighted imaging. J Magn ResonEleven of the false-negative cases were the same for both
fat-saturation methods (two ductal carcinoma in situ, five
invasive lobular carcinoma, three invasive ductal carci-
noma, and one as malignant lesion NOS). However, DWI-
STIR showed four more false-negative cases than -SPAIR
(two highly spread invasive lobular carcinoma, one invasive
ductal carcinoma with in situ component, and one
mucinous carcinoma). Other groups reported similar false-
negative results.39,40 A possible explanation for these
additional misclassified lesions in STIR versus SPAIR could
be related to incomplete fat suppression in the former case.
As lipids present a lower ADC compared to water, the
overall ADC would be lower.
Although artefacts were not quantified, they appeared to
be more prevalent on DWI-SPAIR than -STIR. To minimize
artefacts through the image and field inhomogeneities, a
reduced FOV, automatic first-order shimming, and manual
adjustment of water and fat frequencies were used.
The present study has some limitations. The number of
benign lesions is smaller than malignant lesions, which
could bias the reported positive and negative predictive
values. Also, using 3 T MRI, some authors8,10 reported to be
able to detect lesions with 4 and 3 mm sizes in DW images.
As the lesion size in the present sample was 7 mm, future
work should test the impact of both fat-saturation tech-
niques in the detection of smaller lesions. Additionally,
lesion demarcation was performed by two researchers in
consensus, when in the clinical practice only one researcher
would do it.
In conclusion, image quality, suppression uniformity,
mean ADC values, and the established thresholds used for
lesion differentiation are influenced by the fat-suppression
technique. Both techniques present similar AUC, which
means that either could be used in the clinical setting.
Nonetheless, the DWI-SPAIR technique showed a diagnostic
performance more similar to histology than the -STIR
technique, thus suggesting that the -SPAIR fat-suppression
technique may be overall more accurate.
Conclusion
 The fat saturation technique used in breast DWI in-
fluences image quality.
 Fat suppression uniformity was better for DWI-STIR
than -SPAIR.
 ADC quantification and cut-off values depend on the fat
suppression used.
 Diagnostic performance between DWI-STIR and -SPAIR
was not significantly different.
 DWI-SPAIR seems to be more accurate using as refer-
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